Thank you for joining us for #ASGCT2025! Watch sessions on demand on the virtual platform through July 18!
The ASGCT Board of Directors and the Society's officers have full responsibility for the management, direction and control of the business, policies and affairs of ASGCT, subject only to limitations set forth in the Society's Articles of Incorporation and Bylaws. Learn more about the Board and Officers below.
Paula Cannon, PhD, President
Terence R. Flotte, MD, President-Elect (2024-2025)
Matthew H. Porteus, MD, PhD, Vice President (2024-2027)
Isabelle Riviere, PhD, Secretary
Federico Mingozzi, PhD, Treasurer
Aravind Asokan, PhD
Daniel E. Bauer, MD, PhD
Claire Booth, MBSS, PhD
Lindsey George, MD
Kimberly Goodspeed, MD, Clinical & Translational Council Chair
Punam Malik, MD, Science + Education Council Chair
Kah-Whye Peng, PhD
Miguel Sena-Esteves, PhD
Jennifer Wellman, MS, Membership Council Chair
Joseph C. Glorioso, PhD, Ex-Officio
Jeffrey Chamberlain, PhD, Immediate Past President
Read the full Society Bylaws, which were amended and restated in May 2017.
Sept. 25-26, 2025 | Washington, D.C.
© 2000-2025 All rights reserved. American Society of Gene & Cell Therapy.
Kentico CMS Development by Reason One | Powered by Kentico